Apyx Medical Corporation (APYX) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Apyx Medical Corporation and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.59HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
Total return — APYX vs LUCD
growth of $100 · dividends reinvested · last 5yAPYX -80.6% (-28.0%/yr)LUCD -95.0% (-45.0%/yr)APYX compounded faster over this window
APYX LUCD
APYX vs LUCD: by the numbers
- •LUCD is the larger company ($114M vs $109M market cap).
- •Both run net losses; APYX's is the smaller (-14.78% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | APYX | LUCD |
|---|---|---|
| P/S ratio | 1.87 | 21.01 |
| P/B ratio | 10.23 | 10.47 |
Profitability
| Metric | APYX | LUCD |
|---|---|---|
| Gross margin | 33.94% | -60.26% |
| Operating margin | -6.06% | -1054.82% |
| Net margin | -14.78% | -959.76% |
| ROE | -80.97% | -478.26% |
| ROIC | -6.84% | -145.10% |
Growth (annualized)
| Metric | APYX | LUCD |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | N/A |
| Total return CAGR (5Y) | -28.10% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.